Comparative In Vitro Activity of Three Aminoglycosidic Antibiotics: BB-K8, Kanamycin, and Gentamicin
AUTOR(ES)
Yu, Pauline K. W.
RESUMO
Kanamycin, BB-K8, and gentamicin were tested in parallel against 1,037 bacterial strains isolated from clinical material. The activity of BB-K8 at 20 μg/ml was comparable to that of gentamicin at 8 μg/ml against Pseudomonas aeruginosa and against Enterobacteriaceae, with the exception of gentamicin-resistant strains of Proteus rettgeri and Providencia stuartii, in which case the activities of BB-K8 and kanamycin were the same. BB-K8 exhibited little or no activity against streptococci. The activity of BB-K8 was affected by pH and inoculum size. A regression graph for inhibition data with a 10-μg disk of BB-K8 was developed, and synergistic activity of penicillin and BB-K8 against Streptococcus faecalis was tested.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=444518Documentos Relacionados
- In Vitro Comparison of Four Aminoglycoside Antibiotics: Sisomicin, Gentamicin, Tobramycin, and BB-K8
- In Vitro Studies of BB-K8, a New Aminoglycoside Antibiotic
- Comparative Pharmacokinetics of BB-K8 and Kanamycin in Dogs and Humans
- Properties of an R Plasmid in Pseudomonas aeruginosa Producing Amikacin (BB-K8), Butirosin, Kanamycin, Tobramycin, and Sisomicin Resistance
- Comparative Activity of Sisomicin, Gentamicin, Kanamycin, and Tobramycin